ScripsAmerica Launches Diabetes Patient Supply Pro
Post# of 7769
Posted On: 01/12/2015 8:05:04 AM
ScripsAmerica Launches Diabetes Patient Supply Program through Main Avenue Pharmacy
3 minutes ago - DJNF
Untitled Document
TYSONS CORNER, VA / ACCESSWIRE / January 12, 2015 / ScripsAmerica, Inc. (OTCQB: SCRC) today announced that the Company has launched a diabetes patient supply program through its wholly-owned subsidiary, Main Avenue Pharmacy.
Through the new program, ScripsAmerica now has the ability to provide diabetes patients in certain states with medical supplies that are only available through a physician's prescription and typically covered by medical insurance and Medicare. Main Avenue Pharmacy will work directly with manufacturers and suppliers to provide diabetics with the top medical supplies and will store some inventory of this medical equipment as needed.
Medical supplies that the Company will provide include, but are not limited to meters, test strips, swabs, pens, lancing devices and lancets. The global market for products in the management of diabetes currently stands at $41 billion and is on pace to grow to over $114 billion by 2018, according to a recent report by "Research and Markets."
Bob Schneiderman, CEO of ScripsAmerica, stated, "Scrips is excited to announce that we have entered the rapidly growing market for diabetic medical supplies and believe that our new service has the ability to provide another consistent, long-term revenue stream for Main Avenue Pharmacy. We are confident that the Company can quickly build a sizeable customer base for our diabetic supply program which has already begun generating revenue in December 2014, its first month of operation."
"We also have a marketing subdivision focused on Spanish speaking diabetics, a market segment that we believe is not only growing quickly but is also largely underserved. As with all areas of our business, we expect success and growth to stem from our exceptionally high level of customer service. Additionally, ScripsAmerica plans to capitalize on cross-selling opportunities that will arise as many patients that require medical supplies for their diabetes may require or benefit from Main Avenue's other specialty prescription products," added Mr. Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Seal Point Consulting, LLC
888-959-7095
ir@sealpointconsulting.com
3 minutes ago - DJNF
Untitled Document
TYSONS CORNER, VA / ACCESSWIRE / January 12, 2015 / ScripsAmerica, Inc. (OTCQB: SCRC) today announced that the Company has launched a diabetes patient supply program through its wholly-owned subsidiary, Main Avenue Pharmacy.
Through the new program, ScripsAmerica now has the ability to provide diabetes patients in certain states with medical supplies that are only available through a physician's prescription and typically covered by medical insurance and Medicare. Main Avenue Pharmacy will work directly with manufacturers and suppliers to provide diabetics with the top medical supplies and will store some inventory of this medical equipment as needed.
Medical supplies that the Company will provide include, but are not limited to meters, test strips, swabs, pens, lancing devices and lancets. The global market for products in the management of diabetes currently stands at $41 billion and is on pace to grow to over $114 billion by 2018, according to a recent report by "Research and Markets."
Bob Schneiderman, CEO of ScripsAmerica, stated, "Scrips is excited to announce that we have entered the rapidly growing market for diabetic medical supplies and believe that our new service has the ability to provide another consistent, long-term revenue stream for Main Avenue Pharmacy. We are confident that the Company can quickly build a sizeable customer base for our diabetic supply program which has already begun generating revenue in December 2014, its first month of operation."
"We also have a marketing subdivision focused on Spanish speaking diabetics, a market segment that we believe is not only growing quickly but is also largely underserved. As with all areas of our business, we expect success and growth to stem from our exceptionally high level of customer service. Additionally, ScripsAmerica plans to capitalize on cross-selling opportunities that will arise as many patients that require medical supplies for their diabetes may require or benefit from Main Avenue's other specialty prescription products," added Mr. Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Seal Point Consulting, LLC
888-959-7095
ir@sealpointconsulting.com
(0)
(0)ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼